The two as listed companies have no relationship, but the controlling shareholders of both are enterprises under the State-owned Assets Supervision and Administration Commission (SASAC) Sinopharm's controlling shareholder is Sinopharm Holding, and China Pharmaceutical's controlling shareholder is China General Technology
Information Expansion
Sinopharm Pharmaceuticals Group Pharmaceuticals Company Limited was initiated and established by Sinopharm Corporation, and formally established on December 21, 1999, with the approval of the State Economic and Trade Commission (SETC). State Economic and Trade Commission approval, in December 21, 1999 was formally established. The business scope of Sinopharm includes: organizing the production of pharmaceuticals; sales of chemical raw materials, western pharmaceutical preparations, biochemical drugs, biological products and proprietary Chinese medicines; self-supporting and acting as an agent for the import and export business of all kinds of commodities and technologies; import processing and "three to one subsidy" business; countertrade and re-export trade; the sale of health food and consulting related to the above business. Consultation.On February 18, 2016, Sinopharm announced the suspension of trading; on February 25, Sinopharm released the "Announcement on the Actual Controller's Extension of the Performance of the Relevant Commitments", Sinopharm intends to extend the performance of the relevant commitments to extend the deadline for the completion of the commitments from the original March 11, 2016 to March 11, 2017.
This is the first time that Sinopharm announced the suspension of trading in the company.